Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

42.18 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
42 43 Next >
Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 12.5% in the afternoon session after the company revealed it will offer Eli Lilly's weight-loss medications (Zepbound) on its... 
Via StockStory
Topics Artificial Intelligence Supply Chain
Hims Stock Rockets After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound
The deal allows Hims & Hers to sell Eli Lilly's Zepbound on its telehealth platform. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Check Out What Whales Are Doing With HIMS
 
Via Benzinga
Should You Buy Hims & Hers Stock on the Dip?
Via The Motley Fool
Forecasting The Future: 15 Analyst Projections For Hims & Hers Health
 
Via Benzinga
Why Hims & Hers Stock Just Collapsed
Via The Motley Fool
2 Healthcare Stocks to Watch as JPMorgan Boosts Gilead Rating
JPMorgan's upgrade on Gilead sparks bullish sentiment for the healthcare sector—here's why stocks like Pfizer and Hims & Hers are promising opportunities. 
Via MarketBeat
1 Stock Under $50 on Our Watchlist and 2 to Turn Down
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
Is Hims & Hers Stock Too Cheap to Pass Up?
This high-growth stock may be cheaper than you think. 
Via The Motley Fool
Smart Money Is Betting Big In HIMS Options
 
Via Benzinga
Market Whales and Their Recent Bets on HIMS Options
 
Via Benzinga
Is Hims & Hers Health Stock a Smart Buy After Plunging More Than 50%?
Via The Motley Fool
Topics Earnings
Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped
There's a price war brewing in GLP-1 weight loss drugs, and now it's going global. 
Via The Motley Fool
Hims & Hers Health's Options Frenzy: What You Need to Know
 
Via Benzinga
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 8% in the afternoon session after the U.S. Food and Drug Administration raised concerns about unapproved GLP-1 drugs used for weight... 
Via StockStory
Topics Supply Chain
Why Hims & Hers Stock Tumbled on Tuesday
Bank of America just delivered an incredibly back-handed compliment to Hims & Hers stock. 
Via The Motley Fool
2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Stocks
Is Viking Therapeutics the Next Blockbuster GLP-1 Stock?
Viking Therapeutic may have a GLP-1 blockbuster on their hands with VK2735 as it produces weight loss at 5X the speed of Novo Nordisk's Wegovy GLP-1 drug. 
Via MarketBeat
Why Hims & Hers Stock Popped on Monday
Morgan Stanley had great news for Hims & Hers stock today, so why didn't it upgrade the stock? 
Via The Motley Fool
2 High-Flying Stocks with Exciting Potential and 1 to Turn Down
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated... 
Via StockStory
Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers
From Defiance ETFs
Via GlobeNewswire
Why Hims & Hers Health Stock Just Popped
Via The Motley Fool
4 Top Stocks to Buy Under $100
Here are four stocks to buy now that could offer investors upside in the short and long terms. 
Via The Motley Fool
Hims & Hers Stock Is Down 50% From Its High, but Is This a Buying Opportunity?
Shutting down an acquisition caught investor attention, but there's more to the story. 
Via The Motley Fool
The State of Weight Loss Drugs
Via The Motley Fool
Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Novo Nordisk slashed prices on its GLP-1 obesity drugs as it launches NovoCare to gain compounded GLP-1 users as the compounding labs face deadlines to cease. 
Via MarketBeat
3 Cold Stocks That Can Bounce Back This Week
These three stocks tumbled by at least 20% last week, but they may not be down for long. 
Via The Motley Fool
MarketBeat Week in Review – 03/03 - 03/07
Stocks had another down week despite a mostly benign jobs report; and with the latest reads on inflation coming next week the uncertainty may continue 
Via MarketBeat
Topics Economy
This Could Be a Huge Blow to Hims & Hers Health Stock
Via The Motley Fool
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
42 43 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.